US Cervical Cancer Screening Market expansion is benefiting from the adoption of high-risk HPV testing and improved laboratory automation. These technologies support efficient diagnostic workflows and help healthcare professionals assess the risk of cervical disease. The Cervical Cancer Screening Market is expected to reach US$ 10,678 million by 2031, registering a compound annual growth rate...